Physiological functions and structural features of Gα12/13 proteins - 21/09/25

Abstract |
Heterotrimeric G proteins are pivotal signal transduction molecules that propagate extracellular signals through G protein-coupled receptors (GPCRs) in the cell. Receptor activation initiates diverse signaling cascades depending on the associated G protein, particularly its Gα subunit, which determines assignment to either the Gαs/olf, Gαi/o, Gαq/11, or Gα12/13 family. The downstream signaling pathways of the families Gαs/olf, Gαi/o, and Gαq/11 have been explored to a greater extent than Gα12/13. The Gα12/13 family interacts with Rho GTPases and thereby regulates physiological functions such as cell migration, cell adhesion, cytoskeletal changes, cell proliferation, transformation, angiogenesis, and embryonic development. Dysregulation and overexpression of this Gα protein family has been implicated in the pathogenesis of disorders such as asthma, cardiovascular diseases, and cancer. In view of the crucial functions, in-depth insights into the signaling pathways and structural properties of the Gα12/13 family are essential for their full characterization and for elucidating their role as potential targets for drug research. This review summarizes the key findings reported so far and emphasizes the importance of a thorough investigation of the Gα12/13 family drawing attention to the lacunae regarding their signaling and structural attributes.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Gα12/13 signaling pathways compiled emphasizing the gaps in the signaling pathway databases Reactome, WikiPathways, and KEGG. |
• | In-depth analysis of available structural information about the Gα12/13 family in comparison with other Gα protein structures. |
• | Pinpointing the characteristics of the Gα12/13 family based on sequence identity and similarity comparison with other Gα subunits. |
Keywords : Heterotrimeric G proteins, G protein structure, Gα12/13, GPCRs, Signaling
Plan
Vol 191
Article 118523- octobre 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
